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Inorganic arsenic (iAs), a toxic metalloid, affects
millions of people worldwide, mainly from
drinking contaminated water. Arsenic is a
human carcinogen that targets skin, lung,
bladder, and possibly other sites. iAs and its
methylated metabolites readily cross the placenta and reach the fetus
[National Research Council (NRC) 1999], producing effects ranging
from developmental toxicity to cancer (NRC 1999; Waalkes et al. 2007).
Thus, early-life As exposures are drawing escalating health concerns.
In this issue of Environmental Health Perspectives, Li et al. (2008)
report on iAs metabolism in pregnant Bangladeshi women exposed to
iAs through contaminated water. iAs is metabolized to monomethyl-
arsonic acid (MMA) and dimethylarsinic acid (DMA) for urinary
excretion; urinary As speciation is widely used to assess As methylation
capacity. Arsenic methylation capacity can be influenced by dietary
intake of cysteine, methionine, folic acid, niacin, vitamin B12, and
choline (Steinmaus et al. 2005), and dietary folic acid supplementation
to malnourished arsenicosis patients can decrease As burden by decreas-
ing blood MMA and increasing urinary DMA (Gamble et al. 2007).
However, despite poor micronutrient status and high As exposure, the
pregnant Bangladeshi women showed remarkably efficient As methyla-
tion. The median percentage of urinary DMA (74%) is in the upper
range, and MMA (11%) in the lower range of what is commonly seen
in urine of individuals from developed counties with much better nutri-
tion (Vahter 2007). Women during childbearing years are more effi-
cient at As methylation than men (Lindberg et al. 2007), particularly
during pregnancy. This is likely due to the de novo synthesis of choline
by the phosphatidylethanolamine methyltransferase (PEMT) pathway
(Vahter 2007), which can be up-regulated by estrogen. Thus, the
PEMT pathway may function in malnourished pregnant women to
increase choline production needed for fetal development, and, perhaps
fortuitously for As methylation (Vahter 2007). 
The remarkable efficiency of As methylation in malnourished preg-
nant women could also be an adaptive response to As exposure. Such
adaptation might increase As methylation, and thereby excretion, dur-
ing pregnancy, but perhaps at the expense of later toxicity. Methyl
groups from S-adenosylmethionine are essential to both As and DNA
methylation. DNA methylation status is a well-recognized controlling
factor in gene expression. Furthermore, alterations in DNA methyla-
tion status are a recognized epigenetic mechanism in As carcinogenesis
and are linked with As exposure in various systems (Pilsner et al. 2007;
Waalkes et al. 2004). Gestation is a critical period of cell differentiation
and genetic programming during development, and a highly sensitive
time for initiation of chemical carcinogenesis (Waalkes et al. 2007).
Thus, adaptation to As methylation in malnourished pregnant women
could impact fetal development via altered gene expression. Activation
of the PEMT pathway through estrogen signaling is clearly beneficial
for As methylation (Vahter 2007). In contrast, aberrant estrogen signal-
ing is linked with transplacental As carcinogenesis in mice (Waalkes
et al. 2004, 2007). Arsenic also has potential synergistic effects with
estrogenic carcinogens (Waalkes et al. 2007). Indeed, when in utero As
exposure is followed by diethylstilbestrol treatment in newborn mice,
tumors at multiple sites show synergistic increases in adulthood,
including various estrogen sensitive targets (Waalkes et al. 2007). 
Recent data show that early-life As exposure has significant impact
on human health (Fry et al. 2007; Smith et al. 2006). In newborns
from mothers exposed to iAs through contaminated water in
Thailand, altered transcript profiles in cord
blood include stress-related genes and breast
cancer/estrogen-signature genes (Fry et al.
2007), suggesting an adaptive response to As
and pointing toward future health issues.
Smith et al. (2006) observed a remarkable increase in lung cancer inci-
dence in young adults in Chile who had been exposed to iAs in utero;
this suggests a human transplacental carcinogenic potential for As.
Thus, regardless of the immediate temporal tolerance to As during
pregnancy, preventing early-life As exposure of the fetus and improv-
ing nutritional status of pregnant women may be critical for the health
of future generations.
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